Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 5Sanofi
02 2Alcon Inc
03 1Apotex Inc
04 1Brooks laboratories Limited
05 1Chartwell Pharmaceuticals llc
06 2Epic Pharma. LLC.
07 1Europharma
08 1Farmak JSC
09 1Flagship Biotech International Pvt. Ltd
10 1Gen-Eye
11 4Immedica Pharma
12 2KVK.Tech
13 1Kyiv Vitamin
14 1MEDIMETRIKS PHARMS
15 1Medartuum
16 2Medius Ag
17 1National Pharma
18 1Novartis Pharmaceuticals Corporation
19 3Novartis South Africa (Pty) Ltd
20 6ORIFARM GROUP AS
21 1PHARMOBEDIENT
22 1PRO.MED.CS Praha
23 4Paranova Pharmaceuticals Ab
24 4S.A. Alcon-Couvreur N.V.
25 1Sandoz B2B
26 1Velpharm
27 1World Medicine
01 1Betaxolol 20Mg 28 Combined Oral Use
02 1Betaxolol 5Mg/Ml 5Ml Solution Ophthalmic Use
03 1EYE DROPS
04 17Eye Drop
05 3Eye Drop Suspension
06 1Eye Drops
07 1Eye drops, resolution
08 2Eye drops, suspension
09 1Eye/Ear Drop
10 1Film Coated Tablet
11 1Film-Coated Tablet
12 4OPD
13 5SOLUTION/DROPS;OPHTHALMIC
14 2SUSPENSION/DROPS;OPHTHALMIC
15 8TABLET;ORAL
16 2Tablet
01 2Allowed
02 2Approved
03 1Authorized
04 7DISCN
05 14Deregistered
06 2Generic
07 3Originator
08 8RX
09 12Blank
01 1BETAKSIL
02 8BETAXOLOL HYDROCHLORIDE
03 1BETOPTIC
04 1BETOPTIC PILO
05 1BETOPTIC S
06 1Betacor
07 1Betaxolol PMCS
08 1Betaxolol Velpharm
09 1Betoftan
10 9Betoptic
11 11Betoptic S
12 1Betoptic S 0.25% Ophthalmic Suspension
13 1Betoptic S Single Dose
14 1Betoptic Suspension
15 1Betoptic-S
16 1Betoptic-S Single Dose
17 1Betoptic/Pilo
18 2KERLEDEX
19 2KERLONE
20 1Kerlon
21 1Loxoptic
22 3Blank
01 1Czech Republic
02 3India
03 2Italy
04 3Norway
05 1Russia
06 4South Africa
07 1Spain
08 16Sweden
09 2Switzerland
10 1Turkey
11 15USA
12 2Ukraine
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KERLONE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1989-10-27
Application Number : 19507
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KERLONE
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1989-10-27
Application Number : 19507
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE
Brand Name : KERLEDEX
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG;12.5MG
Packaging :
Approval Date : 1992-10-30
Application Number : 19807
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE
Brand Name : KERLEDEX
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;12.5MG
Packaging :
Approval Date : 1992-10-30
Application Number : 19807
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Kerlon
Dosage Form : Betaxolol 20Mg 28 Combined Oral Use
Dosage Strength : 28 cpr riv 20 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE
Brand Name : BETOPTIC PILO
Dosage Form : SUSPENSION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.25% BASE;1.75%
Packaging :
Approval Date : 1997-04-17
Application Number : 20619
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Betoptic
Dosage Form : Betaxolol 5Mg/Ml 5Ml Solution Ophthalmic Use
Dosage Strength : EYE DROPS 5 ml 5 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.5% BASE
Packaging :
Approval Date : 2000-09-28
Application Number : 75446
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.5% BASE
Packaging :
Approval Date : 2009-11-16
Application Number : 78694
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 1999-10-22
Application Number : 75541
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 1999-10-22
Application Number : 75541
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Eye Drops
Dosage Strength : 0.25% W/V
Packaging : 2.5ml/5ml/10/15ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2008-06-27
Application Number : 78962
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2008-06-27
Application Number : 78962
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.5% BASE
Packaging :
Approval Date : 2001-04-12
Application Number : 75630
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BETOPTIC S
Dosage Form : SUSPENSION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.25% BASE
Packaging :
Approval Date : 1989-12-29
Application Number : 19845
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BETOPTIC
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.5% BASE
Packaging :
Approval Date : 1985-08-30
Application Number : 19270
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.5% BASE
Packaging :
Approval Date : 2000-06-30
Application Number : 75386
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Betoptic
Dosage Form : Eye drops, resolution
Dosage Strength : 5 mg/ml
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Betoptic S
Dosage Form : Eye drops, suspension
Dosage Strength : 2.5 mg/ml
Packaging : Bottle of plastic
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
